| Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling H Keum, TW Kim, Y Kim, C Seo, Y Son, J Kim, D Kim, W Jung, CH Whang, ... Journal of controlled release 325, 359-369, 2020 | 50 | 2020 |
| Sequential and timely combination of a cancer nanovaccine with immune checkpoint blockade effectively inhibits tumor growth and relapse Y Kim, S Kang, H Shin, T Kim, B Yu, J Kim, D Yoo, S Jon Angewandte Chemie 132 (34), 14736-14746, 2020 | 46 | 2020 |
| Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells TW Kim, Y Kim, W Jung, DE Kim, H Keum, Y Son, S Jon Journal of controlled release 331, 74-84, 2021 | 32 | 2021 |
| Antigen-presenting, self-assembled protein nanobarrels as an adjuvant-free vaccine platform against influenza virus S Kang, Y Kim, Y Shin, JJ Song, S Jon ACS nano 15 (6), 10722-10732, 2021 | 18 | 2021 |
| Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma TW Kim, Y Kim, H Keum, W Jung, M Kang, S Jon Molecular Therapy-Oncolytics 26, 1-14, 2022 | 14 | 2022 |
| Tubulin‐based nanotubes as delivery platform for microtubule‐targeting agents J Kim, J Lee, J Lee, H Keum, Y Kim, Y Kim, B Yu, SY Lee, J Tanaka, S Jon, ... Advanced Materials 32 (33), 2002902, 2020 | 13 | 2020 |
| Nanovaccine displaying immunodominant T cell epitopes of fibroblast activation protein is effective against desmoplastic tumors H Shin, Y Kim, S Jon ACS nano 17 (11), 10337-10352, 2023 | 8 | 2023 |
| A Hybrid Platform Based on a Bispecific Peptide–Antibody Complex for Targeted Cancer Therapy B Yu, D Hwang, H Jeon, H Kim, Y Lee, H Keum, J Kim, DY Lee, Y Kim, ... Angewandte Chemie 131 (7), 2027-2032, 2019 | 8 | 2019 |
| Liposomal Delivery of an Immunostimulatory CpG Induces Robust Antitumor Immunity and Long‐Term Immune Memory by Reprogramming Tumor‐Associated Macrophages Y Kim, S Lee, S Jon Advanced healthcare materials 13 (6), 2300549, 2024 | 1 | 2024 |
| CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin Y Jang, YS Cho, A Kim, X Zhou, Y Kim, Z Wan, JJ Moon, H Park ACS Applied Materials & Interfaces 16 (14), 17129-17144, 2024 | | 2024 |
| Glycocalyx‐Mimicking Nanoparticles with Differential Organ Selectivity for Drug Delivery and Therapy D Kim, CH Whang, J Hong, MC Prayogo, W Jung, S Lee, H Shin, Y Kim, ... Advanced Materials, 2311283, 2024 | | 2024 |
| Liposomal Delivery of an Immunostimulatory CpG Induces Robust Antitumor Immunity and Long‐Term Immune Memory by Reprogramming Tumor‐Associated Macrophages (Adv. Healthcare … Y Kim, S Lee, S Jon Advanced Healthcare Materials 13 (6), 2470042, 2024 | | 2024 |
| Fusion protein comprising bp26 and antigenic polypeptide JJS Sangyong Jon, KANG Sukmo, Yujin Kim US Patent App. 18/139,003, 2023 | | 2023 |
| Small lipid nanoparticles, and cancer vaccine including same SY Jon, YJ Kim, SM Kang US Patent App. 17/773,658, 2022 | | 2022 |
| Effective Combination Immunotherapy through Vessel Normalization Using a Cancer‐Targeting Antiangiogenic Peptide–Antibody Hybrid B Yu, D Yoo, KH Kim, TW Kim, S Park, Y Kim, Y Son, J Kim, I Noh, ... Advanced Therapeutics 5 (4), 2100151, 2022 | | 2022 |
| Development of anticancer and antiviral vaccines based on self-assembled nanoparticles Y Kim 한국과학기술원, 2021 | | 2021 |
| Drug‐Delivery Systems: Tubulin‐Based Nanotubes as Delivery Platform for Microtubule‐Targeting Agents (Adv. Mater. 33/2020) J Kim, J Lee, J Lee, H Keum, Y Kim, Y Kim, B Yu, SY Lee, J Tanaka, S Jon, ... Advanced Materials 32 (33), 2070244, 2020 | | 2020 |
